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HIV-infected individuals are at high risk of developing
numerous opportunistic infections. The severity of these
infections may increase proportional to the immunosup-
pression degree. We must pay special attention to
immune reconstitution inflammatory syndrome (IRIS) in
order to prevent worsening symptoms and death. HIV
coinfection is associated with high mortality rate despite
effective antiretroviral therapy.
We present the case of a 42 male patient who was
diagnosed with AIDS and pulmonary tuberculosis in
2011 in our clinic. Our theme includes clinical, biologi-
cal, immunological, virological evolution and therapeu-
tics of this patient.
He was a late-presenter patient with advanced immuno-
depression at baseline: low CD4 count, increased viral load
in blood and cerebrospinal fluid. After a month of tuber-
culosis treatment, antiretroviral therapy was instituted
according to guidelines. During one year the patient sub-
sequently developed IRIS and, one by one, several oppor-
tunistic infections, including CNS involvement.
Thus he presented: Cryptococcus neoformans menin-
goencephalitis resistant to fluconazole with multiple
relapses, TB meningoencephalitis, severe form of CMV
disease with encephalitis, demyelinating lesions, necrotic
ulcerative stomatitis and esophagitis with HSV, systemic
candidiasis, severe bacterial infections with multidrug-
resistant germs. Diagnoses were based on the usual
investigations, including molecular biology techniques
(RT-PCR: Mycobacterium tuberculosis, JC virus,
Cryptococcus neoformans), viral resistance testing, PLEX-
ID, MRI. Viral PLEX-ID identified the presence of
Epstein Barr virus in CSF at a high level. Opportunistic
infections occurred imposed specific therapy and reconsi-
deration of antiretroviral therapy with CNS penetration
ARV (score Letendre). The patient was adherent to ARV
therapy. The evolution was initially favorable under spe-
cific therapy with clinical, immunological and virological
improvement. Unfortunately, about 10 months after diag-
nosis, the patient developed CNS lymphoma possibly in
relationship with increased levels of Epstein Barr virus in
CSF, having fatal outcome.
The evolution of this case pointed out once again that in
a patient with AIDS at the time of initiating ART, it
should be considered the possibility of IRIS and future
opportunistic infections, associated with a poor prognosis.
Therefore it is important to detect persons with HIV
infection in the early stages of the disease in order to
obtain a favorable evolution.
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